Vnitr Lek 2013, 59(5):337-340

Koncept spondyloartritid - editorial

K. Pavelka
Revmatologický ústav Praha, ředitel prof. MUDr. Karel Pavelka, DrSc.

Received: March 1, 2013; Published: May 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pavelka K. Koncept spondyloartritid - editorial. Vnitr Lek. 2013;59(5):337-340.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rudwaleit M. New approaches to diagnosis and classification of axial peripheral spondyloarthritis. Curr Opin Rheum 2010; 22: 375-380. Go to original source... Go to PubMed...
    2. Sieper M, Rudwaleit M, Baraliakos X et al. The Assessment of Spondyloarthritis international Society handbook: a guide to assess spondylarthritis. Ann Rheum Dis 2009; 68: ii1-ii44. Go to original source... Go to PubMed...
    3. Rudwaleit M, van der Heide D, Landewe R et al. The development of ASAS classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-783. Go to original source... Go to PubMed...
    4. Rudwaleit M, Jurik AG, Hermann KGA et al. Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondylarthritis b: a consensual Approach by the ASAS/OMERACT MFRI group. Ann Rheum Dis 2011; 68: 1520-1527. Go to original source... Go to PubMed...
    5. Castilo Gallego C, Sibel Z, Aydin Z et al. Clinical utility of the New ASAS Criteria for spondyloarthritis and the Disease Activity Score. Curr Rheumatol Rep 2011; 13: 395-401. Go to original source... Go to PubMed...
    6. Chou R et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern med 2007; 147: 478-491. Go to original source... Go to PubMed...
    7. Sieper J et al. Comparing referral strategies to diagnose axial spondyloarthritis. RADAR. Ann Rheum Dis 2011; 70: (Suppl. 3): 81.
    8. Poddubnyy D et al. Evaluation of 2 screening strategies for early identification of patients with axial spondylarthritis in primary care. J Rheumatol 2011; 38: 2452-2460. Go to original source... Go to PubMed...
    9. Rudwaleit M, Sieper J Referral strategies for early diagnosis of axial spondyloarthritis. Nat J Rev Rheumatol 2012; 8: 262-268. Go to original source... Go to PubMed...
    10. Rudwaleit M, Haibel G, Baraliakos X et al. The early disease stage in axial spondylarthritis. Arthritis Rheum 2009; 60: 717-727. Go to original source... Go to PubMed...
    11. Braun J, van den Berg R, Baraliakos X et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2011; 70: 896-904. Go to original source... Go to PubMed...
    12. Pavelka K. Doporučení České revmatologické společnosti pro léčbu ankylozující spondylitidy. Čes Revmatol 2012; 1: 4-11.
    13. Barkham N, Keen HI, Coates L et al. Clinical and imaging efficacy of infliximab in HLA B 27-positive patients with MRI. Determined early sacroiliitis. Arthritis Rheum 2009; 60: 946-954. Go to original source... Go to PubMed...
    14. Haibel H, Rudwaleit M, Listing J et al. Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two. Arthritis Rheum 2008; 58: 1981-1991. Go to original source... Go to PubMed...
    15. Song IH, Hermann K, Haibel H et al. Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial. Ann Rheum Dis 2011; 70: 590-596. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.